Cancer Intelligence News
Watch ECCO 15 ESMO 34 press conferences live on ecancer
World leading cancer research will be streamed live as it is announced at the upcoming ECCO-ESMO conference in Berlin, Sunday 20 to Thursday 24 September 2009.
Europe’s biggest cancer conference has, in previous years, dominated the cancer conversation with research from all areas such as policy, chemotherapy, genetics and new types of treatment. The video will be broadcast by open access journal ecancermedicalscience, the ECCO ESMO official multi media partner.
Live content will be available to media only and will be available to view by all in perpetuity from an hour after the press conference, or after the embargo has lifted. Register here to access the webcasts:
www.ecancermedicalscience.com/pressconference
Times of broadcast on ecancer are:
- Sunday 20 September, 16.00 hrs (CEST) in English (embargoed to Monday)
- Monday 21 September, 11.00 hrs (CEST) in German
- Tuesday 22 September, 11.15 hrs (CEST) in English
- Wednesday 23 September, 11.15 hrs (CEST) in English
Topics to be covered include:
- Can aspirin prevent cancer in people with an inherited predisposition to colon cancer?
- Genetic identification of patients who are hypersensitive to radiotherapy improves treatment and avoids side-effects.
- Potentially practice-changing results of phase III trial combining targeted heat therapy with chemotherapy in locally advanced soft tissue sarcoma.
- Largest and most comprehensive study to date investigates links between prostate cancer hormone therapy and heart disease.
- Largest study to date investigates the effect of whole-brain radiotherapy in patients with limited spread of primary cancer to the brain.
- New figures on the numbers of new cancers in Europe caused by excess body fat.
- Pancreatic cancer: drug that reverses resistance to chemotherapy.
ecancer is the official multimedia partner of the ECCO15 ESMO 34 Congress.
Added on: 15/09/2009
